TrialNature medicine2022

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial.

Jingxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.